|

Vaccine Therapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Emory University1

Indications

  • Unresectable Triple-Negative Breast Carcinoma1
  • Locally Advanced Triple-Negative Breast Carcinoma1
  • Early Stage Triple-Negative Breast Carcinoma1
  • Metastatic Triple-Negative Breast Carcinoma1
  • Prognostic Stage IV Breast Cancer AJCC v81

Atlanta, Georgia1 trial

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Grady Health System

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.